DK0398024T3 - Konjugater til tumorlokalisering og/eller tumorterapi - Google Patents

Konjugater til tumorlokalisering og/eller tumorterapi

Info

Publication number
DK0398024T3
DK0398024T3 DK90107187.8T DK90107187T DK0398024T3 DK 0398024 T3 DK0398024 T3 DK 0398024T3 DK 90107187 T DK90107187 T DK 90107187T DK 0398024 T3 DK0398024 T3 DK 0398024T3
Authority
DK
Denmark
Prior art keywords
polyalcohol
tumor
derivatised
protein
conjugates
Prior art date
Application number
DK90107187.8T
Other languages
Danish (da)
English (en)
Inventor
Wolfgang Dr Maier-Borst
Hansjoerg Dr Sinn
Hans-Hermann Schrenk
Eckhard Dr Friedrich
Georgi Dr Graschew
Dieter Prof Dr Woehrle
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of DK0398024T3 publication Critical patent/DK0398024T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/081—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Radiation-Therapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
DK90107187.8T 1989-04-19 1990-03-14 Konjugater til tumorlokalisering og/eller tumorterapi DK0398024T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3912792A DE3912792A1 (de) 1989-04-19 1989-04-19 Konjugate zur tumorlokalisation und/oder tumortherapie, verfahren zu ihrer herstellung sowie diese enthaltende diagnostika und/oder therapeutika

Publications (1)

Publication Number Publication Date
DK0398024T3 true DK0398024T3 (da) 1993-03-29

Family

ID=6378961

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90107187.8T DK0398024T3 (da) 1989-04-19 1990-03-14 Konjugater til tumorlokalisering og/eller tumorterapi

Country Status (7)

Country Link
EP (1) EP0398024B1 (ja)
JP (1) JPH0819156B2 (ja)
AT (1) ATE85894T1 (ja)
DE (2) DE3912792A1 (ja)
DK (1) DK0398024T3 (ja)
ES (1) ES2054137T3 (ja)
GR (1) GR3007136T3 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4334317A1 (de) * 1993-10-08 1995-04-13 Dombaj Gmbh Vorrichtung zur Trennung von dissoziierte Stoffe enthaltenden Flüssigkeitsströmen
DE4435087A1 (de) * 1994-09-30 1996-04-04 Deutsches Krebsforsch Konjugat zur Behandlung von Infektions-, Autoimmun- und Hauterkrankungen
GB0609370D0 (en) * 2006-05-11 2006-06-21 Mock Graham A Process for cross-linking macromolecules
JP2010054305A (ja) * 2008-08-27 2010-03-11 Tohoku Denshi Sangyo Kk 癌罹病の検定に使用するデータの収集方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466951A (en) * 1982-11-12 1984-08-21 University Of California Intracellular trapping of therapeutics or tracer agents

Also Published As

Publication number Publication date
ATE85894T1 (de) 1993-03-15
ES2054137T3 (es) 1994-08-01
EP0398024B1 (de) 1993-02-24
JPH0819156B2 (ja) 1996-02-28
GR3007136T3 (ja) 1993-07-30
DE3912792A1 (de) 1990-10-25
JPH0334999A (ja) 1991-02-14
DE59000908D1 (de) 1993-04-01
EP0398024A1 (de) 1990-11-22

Similar Documents

Publication Publication Date Title
Hussain et al. Modern diagnostic imaging technique applications and risk factors in the medical field: a review
US7394053B2 (en) Systems and methods for multi-modal imaging having a spatial relationship in three dimensions between first and second image data
Cassidy et al. Molecular imaging perspectives
Wehrl et al. Pre-clinical PET/MR: technological advances and new perspectives in biomedical research
Beyer et al. The future of hybrid imaging—part 3: PET/MR, small-animal imaging and beyond
Astolfo et al. In vivo visualization of gold-loaded cells in mice using x-ray computed tomography
DE102005053994A1 (de) Diagnosevorrichtung für kombinierte und/oder kombinierbare radiographische und nuklearmedizinische Untersuchungen sowie entsprechendes Diagnoseverfahren
Morris et al. Diagnostic imaging
Lois et al. Effect of MR contrast agents on quantitative accuracy of PET in combined whole-body PET/MR imaging
Graeser et al. Design of a head coil for high resolution mouse brain perfusion imaging using magnetic particle imaging
US6603991B1 (en) Method and apparatus for dual mode medical imaging system
Tang et al. Imaging radiation-induced gastrointestinal, bone marrow injury and recovery kinetics using 18F-FDG PET
Iftimia et al. Advances in Optical Imaging for Clinical Medicine
DK0398024T3 (da) Konjugater til tumorlokalisering og/eller tumorterapi
Mallard The noes have it! Do they? Silvanus Thompson Memorial Lecture, February 18, 1981
Prasad et al. Imaging Techniques in Veterinary Disease Diagnosis
Eldib et al. Optimization of yttrium‐90 PET for simultaneous PET/MR imaging: A phantom study
KR101126047B1 (ko) Ｐｅｔ－ｍｒｉ 시스템의 ｐｅｔ 장치를 위한 ｒｆ 차폐박스
Brooks et al. Studies on regional cerebral pH in patients with cerebral tumours using continuous inhalation of 11CO2 and positron emission tomography
Karimian et al. CYBPET: a cylindrical PET system for breast imaging
US5250284A (en) Method for increasing nuclear magnetic resonance signals in living biological tissue using zinc
Shi et al. Evolution from Medical Imaging to Visualized Medicine
Sharma et al. Study of image qualities from 6D robot–based CBCT imaging system of small animal irradiator
Morris et al. Physics and medicine 2: diagnostic imaging
Weber et al. Evaluation of 68Ga-PSMA PET/CT images acquired with a reduced scan time duration in prostate Cancer patients using the digital biograph vision